Daily Headlines

PUTTING BREAKING MEDICAL NEWS INTO PRACTICE^™

Tuesday February 26, 2008

TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

Did you know that you can earn CME/CE credit by reading our news reports? Look for the CME designation after the article title.

Heart Failure Incidence Down but Medicare Prevalence Up

DURHAM, N.C. -- Despite a modest decline in heart failure incidence, the small improvement in survival plus a growing population has led to a swelling prevalence of Medicare patients living with the condition, investigators here have found. full story

http://www.medpagetoday.com/Geriatrics/CHF/dh/8490

Survey What Should the FDA Do About Reprint Marketing?

The FDA has issued draft guidelines that would permit marketing of FDA-approved drugs via scientific reprints that discuss unapproved indications -- currently a forbidden practice. Vote

OTHER MEDPAGE TODAY EXTRAS

Blogs

Multimedia

Practice Pointers

Antibiotics May Be Overused Near the End of Life

BOSTON -- Antimicrobial therapy in elderly patients with advanced dementia is common and increases as they near death, raising questions of overuse, researchers here said. full story

http://www.medpagetoday.com/Neurology/Dementia/dh/8486

Recurrence Rates Similar for Pulmonary Embolism and DVT

HAMILTON, Ontario -- Three-year rates of recurrent venous thromboembolism did not differ between patients with a pulmonary embolism and those with isolated deep vein thrombosis (DVT), researchers found. full story

http://www.medpagetoday.com/Cardiology/VenousThrombosis/dh/8497

Pfizer Yanks Jarvik Atorvastatin (Lipitor) Ads After Congressional Inquiry
WASHINGTON -- Pfizer said today that it was pulling the plug on advertising that features Robert Jarvik, M.D., promoting the benefit of atorvastatin (Lipitor). full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/dh/8495

ASA: U.S. Leads Europe in Stroke Occurrence

NEW ORLEANS -- Stroke is more common in the U.S. than in Europe, a phenomenon that may reflect better primary prevention there. full story

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/dh/8494

ASA: Aspiration System Aids Reperfusion in Limited Trial

NEW ORLEANS -- In 82% of ischemic stroke patients, removing clots mechanically using a new aspiration device achieved good reperfusion and improved function, researchers reported here. full story

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/dh/8493

Patient Involvement Doesn’t Guarantee Better Outcomes

IOWA CITY, Iowa -- Patients who take an active role in their healthcare may not always wind up in better health than those who prefer to let their physician take the lead, researchers here found. full story

http://www.medpagetoday.com/Nephrology/Hypertension/dh/8491

Probing Mitochondria for Statin Myopathy Mystery

BOSTON -- Studies of the mitochondria have offered hints into the etiology of the myopathy that strikes a small percentage of those who take lipid-lowering statins -- heretofore a puzzle for clinicians. full story

http://www.medpagetoday.com/Cardiology/Dyslipidemia/dh/8489

ASA: Stroke Risk Factors May Hasten Cognitive Decline

NEW ORLEANS -- Some of the major stroke risk factors appear to be the same as those that increase the rate of cognitive decline in older patients, a large cohort study suggested. full story

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/dh/8466

For-Profit Rating Company Names 50 Hospitals as Nation’s Best

GOLDEN, Colo. -- A healthcare rating company here has named 50 American hospitals with an eight-year track record of stellar rates of avoiding major complications and patient deaths. full story

http://www.medpagetoday.com/InfectiousDisease/PublicHealth/dh/8485

ASA: Lowering Blood Pressure Helps in Acute Stroke Therapy

NEW ORLEANS -- Aggressively reducing blood pressure in patients suffering acute ischemic or hemorrhagic stroke appears to be safe and effective, according to two pilot studies. full story

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/dh/8472

ASA: Donepezil (Aricept) Comes Up Short in Vascular Dementia Trials

NEW ORLEANS -- The Alzheimer’s disease drug donepezil (Aricept) does not improve cognition in patients with a genetic form of subcortical ischemic dementia known as CADASIL. full story

http://www.medpagetoday.com/MeetingCoverage/ASAMeeting/dh/8480

Cardiovascular Mortality Linked to Donor Kidneys with Extended-Criteria

SURESNES, France -- Expanded-criteria donor kidneys may confer aortic stiffness in recipients that increases cardiovascular mortality, investigators here suggested. full story

http://www.medpagetoday.com/Nephrology/KidneyTransplantation/dh/8483

CME SPOTLIGHT

Managing CardioMetabolic Complexities
You are invited to participate in the following free educational activity where you will learn about the interrelated factors contributing to the metabolic syndrome and novel therapeutic strategies aimed at attenuating cardiometabolic risk while delaying disease progression.
Source: SciMed New York [more]

Heart Failure: From Emergency Department to Discharge
Join Drs. Frank Michota and Charles Emerman, as they provide the evidence-based science to support physicians in making critical decisions about appropriate ADHF management. This interactive CME activity will review effective diagnosis and treatment strategies in the ED, during admission, and after discharge to prevent rehospitalizations and improve patient healthcare outcomes.
Source: Med-IQ [more]

Overview of Menopause: The Cycle of Vasomotor Disturbances
This virtual symposium will help clinicians who treat patients with vasomotor symptoms evaluate the latest data available to formulate patient-specific treatment plans, and will familiarize physicians with the need to communicate with their patients on alternative therapies and how those therapies may interact with prescription medications.
Source: The Chatham Institute [more]

Waking Up to the Problem of OSA: Consequences and Improved Recognition
This neuroscienceCME VOICE activity will sharpen your awareness of OSA and arm you with screening tools and strategies to improve recognition and management, especially in populations that do not present with classic symptoms. Please register today.
Source: CME Outfitters [more]

New Frontiers in Targeted Therapy for Renal Cell Carcinoma
This activity is designed to educate clinicians on the most common malignancy of the kidney, renal cell carcinoma. Review evolving treatment strategies and best practices with Drs. Escudier, Eisen, and Rini.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Management of Recurrent Metastatic NSCLC?Chronic Treatment with Biologic Agents
Illustrated by a relevant case study, Roy S. Herbst, MD, PhD, examines the current thinking on selecting patients with advanced NSCLC for EGFR genetic testing and treatment with EGFR inhibitors. Includes expert audio commentary by Corey J. Langer, MD, FACP.
Source: Projects In Knowledge [more]

neuroscienceCME Journal Club
Trouble keeping up with the latest findings from the clinical literature? neuroscienceCME Journal Club can help. Hear leading authors talk about just-published articles, and then answer your questions. Hosted by Thomas Roth, PhD.
Source: CME Outfitters [more]

The Science and Strategy of Biopreparedness: Critical Agent Update and Emerging Disease Threats
This activity employs an expert faculty to explore state-of-the-art knowledge about potential biological threats (Avian Influenza, Smallpox and Toxins), preventive measures and treatments currently available and on the horizon.
Source: Annenberg Center for Health Sciences at Eisenhower [more]

Advancing Patient Care in IBD: A Clinically Relevant Perspective
The following CME certified webcast brings participants clinical pearls from national and international experts in the area of IBD. The clinical utility of conventional agents and available biologic therapies are reviewed. Chaired by Dr. Gary Lichtenstein.
Source: University of Pennsylvania School of Medicine [more]

Managing the Symptomatic Menopausal Patient in Primary Care: A Case-Based Approach
This interactive CME activity provides practical recommendations and the latest clinical evidence to improve the personalized care a women receives during menopause.
Source: Interstate Postgraduate Medical Association and MEV Healthcom, Inc. [more]

New phase 3 trials may dramatically alter the management of newly diagnosed myeloma.
This activity reviews these trials as well as new developments in transplantation and relapsed/refractory therapies.
Source: Curatio CME Institute [more]

Emerging Patient Challenges in COPD: Interactive Case Simulator
Designed for primary care clinicians. This case-based CME activity provides a virtual learning experience, allowing participants to order diagnostic tests, prescribe drugs, diagnose and develop new treatment strategies; simulating clinical practice.
Source: CASIVUS [more]

Pathophysiology of Vasomotor Symptoms: Thermoregulatory and Cognitive Issues
This virtual symposium will help clinicians to better recognize factors contributing to the pathophysiology of vasomotor symptoms, and evaluate the latest data available to formulate patient-specific treatment plans.
Source: The Chatham Institute [more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Novel Insights Into Cardiometabolic Disease
Hypertension is a major risk factor for the development of both cardiovascular and renal disease in patients with diabetes. The following certified webcast offers cardiometabolic disease management strategies that can be applied across diverse patient populations.
Source: SciMed New York [more]

RESOURCES

Now Approved: A new development in the treatment of hypertension.
Now approved from Forest Laboratories: Bystolic (nebivolol). A novel beta blocker for the treatment of hypertension. Click here to learn more. Source: Forest Labs [more]

Explore the Possibilities in Type 2 Diabetes.
Explore the Possibilities in Type 2 Diabetes. Source: Merck [more]

Featured Job Opportunities from MedJobs Today

Surgery, Kentucky
Practice a full range of general surgery including endoscopies.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17439&refsrc=dh
Surgery, New Mexico
Work in a no trauma facility doing clinic and call coverage.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17582&refsrc=dh
General Surgery, Oregon
We will consider candidates Board Eligible within 5 years.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17652&refsrc=dh

Visit MedJobs Today.com to search for a new job!

APSS Meeting

APSS: Extra Health Cost of Insomnia Reaches $3,200 an Employee

AGS Meeting

AGS: Methylnaltrexone Demonstrates Efficacy for Treatment of Opioid-Induced Constipation

ACC Meeting

ACC: Mixed Messages on Heart Failure Disease Management

ASCO Meeting

ASCO: Chemotherapy Doesn't Help in Malignant Mesolthelioma

Get tools, resources & information about Gleevec matching the experience of attendees of the 2007 ASH Annual Meeting.

Did you miss the Gleevec booth at the 2007 ASH Meeting? Get tools, resources and information about Gleevec via a fully interactive virtual exhibit booth, matching the experience of attendees of the 2007 ASH Annual Meeting.

Source: Novartis Oncology.

At MedPage Today™, we’re PUTTING BREAKING MEDICAL NEWS INTO PRACTICE™.

You have received this email because you have registered to receive alert emails at www.medpagetoday.com, with the email address: delphine1939@videotron.ca. You can easily manage your subscriptions by clicking on the "Edit Profile" link below.

SUBSCRIBE OR UNSUBSCRIBE:
Edit Profile

TECHNICAL QUESTIONS:
webmaster@medpagetoday.com

MedPage Today, LLC.
Overlook at Great Notch
150 Clove Road
Little Falls, New Jersey 07424
Telephone: (973) 890-0985
Fax: (973) 890-1327